Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
-
▾0.00 (0.00%)
Last trade: 29/10, 4:27PM
Market cap
-
Market closed
Talk to Sienna Cancer Diagnostics Limited directly.
Sign up to their Investor Hub for direct access to the Sienna Cancer Diagnostics Limited team, ask them questions, and see personal updates.
Sienna Cancer Diagnostics Limited has been removed from the Australian Securities Exchange official list as of 28/07/2020
Investor Presentations
Principal Activity
Sienna Cancer Diagnostics Limited (SDX) is an Australian company focused in identifying, developing and commercialising diagnostic technologies which satisfy an unmet clinical and market need in the detection, characterisation and monitoring of cancer. SDX manufactures IVD (in vitro diagnostic) products for pathology laboratories to use in their menu of testing services. SDX has IVD product registration for their Anti-hTERT Antibody (SCD-A7) in several key markets including the USA, European Union and Australia.
Address
1 Dalmore Dr, Scoresby VIC 3179, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
-
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.